Conditions: Generalized Anxiety Disorder
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 615
Healthy volunteers: no

Brief summary:
The purpose of this study is to characterize the safety and efficacy in patients with generalized anxiety disorder after short- (3 months) and long-term (6 months) use of Pregabalin (Lyrica).

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None

Interventions: intervention 1: Pregabalin intervention 2: Lorazepam intervention 3: Pregabalin intervention 4: Placebo
Intervention descriptions: intervention 1: Pregabalin 150-300 mg given twice a day intervention 2: Lorazepam 3-4 mg given twice a day intervention 3: Pregabalin 450-600 mg given twice a day intervention 4: Placebo

Protocol document: